This study evaluates the influence of vitamin D in reducing laboratory, elastographic
(Fibroscan) and metabolic components of NAFLD. Half of the patients will receive vitamin D
(Plivit D3) while the other half will receive placebo
Phase:
Phase 4
Details
Lead Sponsor:
University Hospital Rijeka
Collaborators:
Pliva Hrvatska d.o.o. University of Rijeka
Treatments:
Cholecalciferol Dihydroxycholecalciferols Ergocalciferols Vitamin D Vitamins